Member Info for LlamaFarmer

H t t p s: / /t. m e/+8FD4QMxNcORkYmM0

Remove spaces put in search bar, may need to download telegram app first, google can explain it better than me.

Bufflehead, you are welcome to join?

You can load diagrams, research notes etc.

The more informative ones can be pinned as a research resource to go back over and help remind and review why you are invested and what the next stages we all think will be?

Let me know I can put a link on.

DVH,

Apologies, curse of assumption, someone with same initials in there.

You should join, its for investors over traders but both will benefit imo?

Waited a long time for this, market starting to see what they have here.

DV Harrison,

The Telegram group's purpose has nothing to do with any of the casual LSE/ADVFN observers, wasn't designed for them or the traders.

LSE and ADVFN are unfit for purpose, the market and it's investors have mainly moved on to text and graphics based platforms, easier to see charts, diagrams etc.

The Company have 6.4B shares in issue, lots of private investors and small II's, it is going to get these price fluctuations until the business takes it to the next footing, we know what the road map is as the CEO has supplied us with a few podcast interviews recently.

The share price has cooled down from the top of the Bollinger band and is sitting on or near to the bottom of same, if you look at a chart with volume and BB indicators you will see it.

I know you know all of this as you are in the elegram group and read what I read?

Personally this was the opportunity I was waiting for to increase my holding, added at under the placing price of 0.30 that went to 3 hand picked long term investors i.e. Sticky holders who could be trusted to hold.

Also worth understanding that Awakn, now Solvonis have been treating Americans in their private clinics since 2023 with the pre Phase 2b drug (Awkn002) SVN002.

Once the bridging data is provided by the HongKong / Chinese lab to the FDA we can expect SVN002 to,

1.Be rolled out into all of the Spravato clinics

2.Be worth an awful lot of money.

Before that SVN001 will be licensed in the UK to provide funding for Professor Nutts CNS Library ...

Toronto, Ontario--(Newsfile Corp. - April 12, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), is today providing a corporate update.

Dr. Ben Sessa has resigned from his role as Head of Psychedelic Medicine at Awakn and will leave the business effective April 13. As a result of Dr. Sessa leaving Awakn, Dr. Sessa has agreed to transfer his 49% stake of Awakn Bristol Limited, which operates Awakn Clinics Bristol, to Awakn Life Sciences Inc., a wholly owned subsidiary of Awakn, resulting in Awakn Life Sciences Inc. holding a 100% interest in the Bristol operation.

Nushama Inc., a licensing partner of Awakn based in Manhattan, New York, has treated its first clients with Awakn's novel treatment for Alcohol Use Disorder, Awakn Kare, marking the first people in North America to receive the treatment.

Awakn has completed the filing of three Patent Cooperation Treaty (PCT) applications for its New Chemical Entity program. As a result, and pursuant to the Intellectual Property Transfer Agreement among Awakn, Awakn Life Sciences Inc. and Equasy Enterprises Ltd. dated March 8, 2021, as amended, an additional 70,000 common shares of Awakn are issuable to Prof. David Nutt.

Someone is running for the door and two transactions have gone through at 0.30p.

The first at £1m 0.30p to existing funders

The Second 60,142,923 shares at an issue price of £0.30p for £180,428.77p

Q4 starts in 33 days - it gets frothy then!

Would explain todays carnage!

I was on the slopes that day, saw the rescue, joke in bad taste.

Chat gpt is machine learning so is programmable - wouldn't trust it without additional info.

Cavendish note shows it's an improving ebitda.

They massaged the accounts with the Abiss purchase of Euro 80k against its market valuation, showed a profit of £1k, that may be where you are getting confused.

2 X European competitors have pulled out of Europe, Abiss have manufacturing capacity.

Contract manufacturing and Heart Valves is showing signs of life.

If you can carry on selling that's great ideally 10p would be a good price for me.

It's looking better that it has for years, has cash, won't need to raise unless it attracts sizeable contracts that require more kit which would mean an increase in the S.P.

Bod have organised the company into new Divisions which seem to be cracking on.

Comment re: results from a united workforce are positive.

French subsidiary looks a gift with 2 x competitors leaving European theatre.

Bought some now for 2026.

This looks completely beaten down, but equally on the cusp of something new?

Someone tipped me this one to look at and I briefly did until researching more on Solvonis instead, then a close friend had a 10 hour operation with reconstructive surgery and I went back to this and fell down a rabbit hole.

In 2021, Bill Brown promoted the business with some very covid type interviews, Bill came across well, the interviewers nostrils not as good.

He said there were contracts in bound but since then the share chart has nose dived as the market and opportunities moved against him and they restructured into the current division.

Since then he has kept his own council, but more importantly keep plugging away at the business, can't blame him for the silence.

There has been very good news flow, contract manufacturing, heart valves and the Abiss purchase, aslong with the hole in European manufacturing looks like Bills 2021 interview is now ready.

Looking at the chart I get that a lot of LTH may be underwater but like every recovery stock there is a timing to possibly average down or realise that all is not lost.

This won't be a mining or treasury play so won't attract the "froth" or the losses, but from here, it looks a nice, stable play to park some money while the Company expands over the next year or two.

Look up Electrum then reread the assay results ...

Smller,

Ive no wish to point score off of you so will leave it there.

If you wish to try and make the -90% a -95% I guess thats your business.

I dont understand the pointless arguments from either side and daily ability to re-engage

repetitively, its boring to read.

Smiller, or to put it another way, its like you are telling me,

Lauren Bacall and Liz Taylor are the most beautiful women in the world and im looking going sure they were, but they are both dead, there are new candidates here now why didnt you move with the times?

Smiller, so if i've got a lot more than £10k in at the lows, I've got more skin in the game here, today, now?

I'm not understanding the arguments or the logic ?

If the £100k investors are 90% down, they only have £10k skin in the game dont they?

Don't understand the arguing on these boards?

The Telegram group was designed for a few of us to put research notes in at 0.13p to have notes, links to web pages, interviews with the BOD, wider industry detail etc, a couple of us had been in since 0.10p and followed the story as Awakn and Graft Polymer merged so was good to have a pooled resource to look back over details and track progress.

Both of those investors independently identified mos last year at 0.0425p and then again SVNS at 0.10p.

It wasn't and isn't a chat group as such , operates a no 6xxxxx policy so can go "quiet" until someone turns up some research.

What tends to happen, is people log on and review info to remind them of why they are invested .

Anyone welcome, trader or investor but please leave the lse behaviour for lse.

Either an o or a zero at the end